The Human Intestinal Microbiome in Health and Disease.

  title={The Human Intestinal Microbiome in Health and Disease.},
  author={Susan V. Lynch and Oluf Pedersen},
  journal={The New England journal of medicine},
  volume={375 24},
  • S. LynchO. Pedersen
  • Published 14 December 2016
  • Medicine, Biology
  • The New England journal of medicine
The large majority of studies on the role of the microbiome in the pathogenesis of disease are correlative and preclinical; several have influenced clinical practice. 

Figures from this paper

The human microbiota and infection prevention

A summary of the methodological principles used in microbiome studies and the published evidence of the impact of microbiome dysbiosis in infection prevention are provided.

Potential biomarkers of infertility associated with microbiome imbalances

Infertile patients showed a lower bacterial richness and increased Firmicutes/Bacteroidetes ratio at rectal level and an increased Lactobacillus brevis/LactobACillus iners ratio in vaginal samples regarding the fertile group and miRNAs could be potential biomarkers of the inflammatory impact of microbiome disbalances in unexplained infertile women.

The Integrative Human microbiome project: a mile stone in the understanding of the gut microbiome

In the past several years, innovative technologies have allowed for the identification and quantification of the human microbiome composition and function to be identified and quantified.

Gut microbiome-immune crosstalk affects progression of cancer.

The dramatic explosion of genetic tools and metagenomic techniques in the last decade allowed to characterize the composition of the microbiome from several areas of the body and increasingly enables scientists to link composition and changes with human health and more importantly with various disorders far beyond the gastrointestinal tract.

Patients with psoriasis have a dysbiotic taxonomic and functional gut microbiota *

The gut microbiota of patients with autoimmune disease and the role of the gut microbiota in patients with psoriasis have demonstrated conflicting results and have mainly been based on 16s rRNA gene sequencing analysis.

The genome, microbiome and evolutionary medicine

  • R. Brunham
  • Biology, Medicine
    Canadian Medical Association Journal
  • 2018
This book presents a demonstration — through a greater understanding of the human genome and the microbiome — that evolutionary biology underpins the principles and practice of medicine.

The intestinal microbiome influences checkpoint blockade

Studies in metastatic melanoma, non-small-cell lung carcinoma and renal cell carcinoma indicate certain bacteria within the gut microbiota enhance clinical responses to checkpoint blockade.

Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi‐Omics

This work investigated fecal microbiome and metabolome alterations in PD, and their clinical relevance, and concluded that gut microbiome alterations in Parkinson disease are likely to be influenced by environmental factors.



Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double‐blind, placebo‐controlled crossover study

Ageing can result in major changes in the composition and metabolic activities of bacterial populations in the large gut and an impaired immune system.

Isolation and characterization of bacteriocin‐producing bacteria from the intestinal microbiota of elderly Irish subjects

To isolate and characterize bacteriocins produced by predominant species of lactic acid bacteria from faeces of elderly subjects, using single-use nanofiltration membranes for the first time.

Early-Life Exposure to Antibiotics, Alterations in the Intestinal Microbiome, and Risk of Metabolic Disease in Children and Adults.

The natural evolution of the intestinal microbiome from the perinatal period into early childhood, the effect of antibiotics on the microbial ecology, and the implications for future health and disease are explored.

Intestinal microbiota in human health and disease: the impact of probiotics

The effects of probiotic consumption on the intestinal microbiota are addressed, as well as the development of tailor-made probiotics designed for specific aberrations that are associated with microbial dysbiosis.

Linking Microbiota to Human Diseases: A Systems Biology Perspective

HIV-induced alteration in gut microbiota

It is proposed that understanding the mechanism of HIV-associated gut microbiota changes will elucidate the role of adaptive immunity in shaping gut microbiota composition, and lay the foundation for therapeutics targeting the microbiota to attenuate HIV disease progression and reduce the risk of gut-linked disease in people with HIV.

The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment

Altered alterations in the gut, dental or saliva microbiome distinguished individuals with RA from healthy controls, were correlated with clinical measures and could be used to stratify individuals on the basis of their response to therapy.

The gut microbiota and host health: a new clinical frontier

The potential of manipulating the gut microbiota in these disorders is assessed, with an examination of the latest and most relevant evidence relating to antibiotics, probiotics, prebiotics, polyphenols and faecal microbiota transplantation.